• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-620
Device Problem Imprecision (1307)
Patient Problem Hyperglycemia (1905)
Event Date 01/06/2023
Event Type  Injury  
Manufacturer Narrative
The manufacturer is currently performing an investigation and will provide the results with the supplemental report.
 
Event Description
On (b)(6) 2023, senseonics was made aware of an adverse event where user experienced hyperglycemia symptoms due to inaccuracies in sensor readings and system did not alert the user.
 
Manufacturer Narrative
Based on the investigation analysis, estimated values provided by the app were entered as calibrations instead of the customer using their true bg values.Entering an estimated value or accepting the value from the eversense cgm system instead of entering a true, measured, bg value can disrupt the calibration and lead to significant deviations in sensor readings.The estimated bg values impacted the accuracy of the sensor readings and led to missing a potential medical adverse event.The user did not seek any medical attention and was able to self-treat for hyperglycemia.The user was educated about the importance of performing calibrations using true fingerstick bg values.Once the user understood the importance of proper calibration and the sensor passed the early wear adjustment period, the system began displaying good agreement between the sensor readings and calibration entries.User is currently using the system and no further investigation was found necessary for this complaint.H3.Device evaluated by manufacturer? yes.H6.Investigation findings updated to 213.H6.Investigation conclusions updated to 18.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20875-7005
MDR Report Key16301671
MDR Text Key308824029
Report Number3009862700-2023-00023
Device Sequence Number1
Product Code QHJ
UDI-Device Identifier00817491022936
UDI-Public817491022936
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/09/2023
Device Model Number102208-620
Device Catalogue NumberFG-5902-01-001
Device Lot Number129006
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/08/2023
Initial Date FDA Received02/04/2023
Supplement Dates Manufacturer Received01/08/2023
Supplement Dates FDA Received04/28/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/09/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age59 YR
Patient SexFemale
-
-